Olin J et al. A plasma proteogenomic signature for fibromuscular dysplasia. Cardiovasc Res. 2020 116(1) : 63-77.

Stojkovic S, Koller L, Sulzgruber P, Hülsmann M, Huber K, Mayr M, Hengstenberg C, Wojta J, Niessner A. Liver-specific microRNA-122 as prognostic biomarker in patients with chronic systolic heart failure. Int J Cardiol. 2020 19, 33664-2.

Foinquinos A et al. Preclinical development of a miR-132 inhibitor for heart failure treatment. Nat Comm. 2020 11(1), 633.

Capoulade R et al. APOCIII=Lp(a) complexes in conjuction with Lp(a)-OxPL predict rapid progression of aortic stenosis. Aortic and Vascular Disease. 2020 106(10) : 738-745.

Burnap S et al High-Density Lipoproteins Are the Main Carriers of PCSK9 in the Circulation. J Am Coll Cardiol. 2020 75(12), 1495-1497.

Barallobre-Barreiro J et al. Extracellular Matrix in Vascular Disease, Part 2/4 J Am Coll Cardiol. 2020 75(17):2189-2203.

Yang X et al. FURIN Expression in Vascular Endothelial Cells Is Modulated by a Coronary Artery Disease-Associated Genetic Variant and Influences Monocyte Transendothelial Migration. J Am Heart Assoc. 2020 9(4) : e014333.

Parter W et al Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels. Cardiovasc Diabetol. 2020 19(1) : 3.

Krammer et al. microRNAs as Promising biomarkers of Platelet Activity in Antiplatelet Therapy Monitoring. Int J Mol Sci. 2020; 21(10) : E3477

Gutmann C. et al. The Landscape of Coding and Non-coding RNas in Platelets. Antioxidants & Redox Signaling. 2020 .

Foinquinos A et al. Preclinical development of a miR-132 inhibitor for heart failure treatment. Nat Comm. 2020 11(1), 633.

Corral-Acero J. et al. The Digital Twin to enable the vision of precision cardiology Eur Heart J.2020; 4 :. ehaa159

Braza-Boils A. et al. Circulating MicroRNA Levels Indicate Platelet and Leukocyte Activation in Endotoxemia Despite Platelet P2Y12 Inhibition. Int J Mol Sci. 2020 21(8) : 2897.

Chan M. et al Platelet reactivity in Individuals Over 65 Years Old Is not Modulated by Age.Circ Res. 2020.